In check dial: accuracy for Diskus and Turbuhaler

被引:34
作者
Broeders, MEAC
Molema, J
Vermue, NA
Folgering, HTM
机构
[1] Univ Nijmegen, Dept Pulm Dis Dekkerswald, NL-6560 GB Groesbeek, Netherlands
[2] GlaxoSmithKline, NL-3705 LZ Zeist, Netherlands
关键词
dry powder inhaler; peak inspiratory flow; in check dial;
D O I
10.1016/S0378-5173(02)00650-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: The In Check Dial was developed to evaluate whether a patient is able to generate an adequate peak inspiratory flow (PIF) through a certain inhalation device. The inhalation profile recorder (IPR) is a calibrated instrument that measures flows through Diskus and Turbuhaler in our research setting. The aim of this study was to compare the PIFs of patients when inhaling through a Diskus or Turbuhaler connected with the IPR (PIF-diskus and PIF-TH) to the flows through the corresponding orifices of the In Check Dial (Diskus_In Check and TH_In Check). Methods: Twenty-four stable asthma and twenty-one chronic obstructive pulmonary disease (COPD) patients inhaled, on two separate occasions, in randomised order, via the Diskus or Turbuhaler connected with the IPR. Subsequently, patients inhaled through the In Check Dial using the orifices of Diskus or Turbuhaler. Results: The difference between Diskus_In Check and PIF_diskus was 3.9 (11.9) 1/min (P = 0.038). The difference between TH_In Check and PIF_TH was 3.5 (10.6) 1/min (NS). All Diskus- and Turbuhaler-inhalations were performed with the minimum required flow of 301/min. However, four COPD patients inhaled with the non-optimal flow (<601/min) through the Turbuhaler. The In Check Dial did not indicate two of them. Conclusion: Measuring PIF through Diskus and Turbuhaler using the IPR and the In Check Dial, respectively shows a disagreement of 3.91/min. A disagreement of 3.51/min was found for the Turbuhaler. The In Check Dial did not identify two of four patients as 'non-optimal' users. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:275 / 280
页数:6
相关论文
共 14 条
  • [1] [Anonymous], 1987, AM REV RESPIR DIS, V136, P225
  • [2] Fine particle mass from the Diskus inhaler and Turbuhaler inhaler in children with asthma
    Bisgaard, H
    Klug, B
    Sumby, BS
    Burnell, PKP
    [J]. EUROPEAN RESPIRATORY JOURNAL, 1998, 11 (05) : 1111 - 1115
  • [3] STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
    BLAND, JM
    ALTMAN, DG
    [J]. LANCET, 1986, 1 (8476) : 307 - 310
  • [4] On the use of dry powder inhalers in situations perceived as constrained
    Borgström, L
    [J]. JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 2001, 14 (03): : 281 - 287
  • [5] LUNG DEPOSITION OF BUDESONIDE INHALED VIA TURBUHALER(R) - A COMPARISON WITH TERBUTALINE SULFATE IN NORMAL SUBJECTS
    BORGSTROM, L
    BONDESSON, E
    MOREN, F
    TROFAST, E
    NEWMAN, SP
    [J]. EUROPEAN RESPIRATORY JOURNAL, 1994, 7 (01) : 69 - 73
  • [6] BRINDLEY A, 1995, PHARM TECH EUR, V7, P14
  • [7] Resistivities of placebo and active Diskus® inhalers compared
    Broeders, MEAC
    Molema, J
    Folgering, HTM
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 228 (1-2) : 219 - 222
  • [8] Dekhuijzen P N, 1998, Ned Tijdschr Geneeskd, V142, P1369
  • [9] ENGEL T, 1990, EUR RESPIR J, V3, P1037
  • [10] General factors influencing drug delivery to the lung
    Ganderton, D
    [J]. RESPIRATORY MEDICINE, 1997, 91 : 13 - 16